Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
13 | 30505047 | intron variant | T/C | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
13 | 30488053 | intron variant | T/A;C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
13 | 30497658 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
13 | 30496075 | intron variant | T/C | snv | 0.81 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
13 | 30496075 | intron variant | T/C | snv | 0.81 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
13 | 30499729 | intron variant | G/C;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.695 | 0.440 | 13 | 30463766 | 5 prime UTR variant | G/A;C;T | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 |